Nasdaq: IAM · Listed Oct 15, 2026
Iambic Therapeutics IPO
$14.61
▲ +2.74%today · -8.69% since the $16.00 IPO price
15-minute delayed · as of 6:27:39 AM EST on Nov 19, 2026
Iambic Therapeutics (IAM) priced its IPO at $16.00 a share and has traded on Nasdaq since Oct 15, 2026.
Last session · Nov 18, 2026
- Market cap
- $699.64M
- from the ticker reference
- Volume
- 290.11K
- shares, regular session
- VWAP
- $14.82
- the last price is -1.43% from the volume-weighted average
- Day range
- 14.10–15.42
- low to high
The trading numbers are from the last session, Nov 18, 2026.
The debut race
IAM against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
IAM against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Iambic Therapeutics '26 | $150M | +0.94% | +18.19% | -1.38% | Not yet | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Iambic Therapeutics IPO offers 9.38M shares to raise $150M, before any underwriters' option.
- Expected price range
- $15 to $17
- IPO price
- $16.00
- Shares offered
- 9.38M
- Money raised
- $150M
- Listing date
- Oct 15, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Iambic Therapeutics$150M
Where IAM ranks
Iambic Therapeutics's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- IAM$699.64M
What comes after the IPO
Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.
Oct 15, 2026
First trade
Prices, bars, and snapshots
Oct 20, 2026 · est.
Options list
Option chain and open interest
Nov 4, 2026 · est.
First short interest
Short interest and daily short volume
Nov 9, 2026 · est.
Quiet period ends
Analyst ratings and price targets
Feb 14, 2027
First 13F deadline
Which funds hold the stock
Date not set
First earnings
Income statement and ratios
Apr 12, 2027 · est.
Lock-up expires
Insider sales on Form 4
Filings and the company
What Iambic Therapeutics has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Iambic Therapeutics discloses to the SEC on Form 8-K.
- Charter amendmentOct 16, 2026
On October 16, 2026, Iambic Therapeutics, Inc. (the "Company") filed an amended and restated certificate of incorporation (the "Restated Certificate") with the Secretary of State of the State of Delaware in connection with the completion of the Company's initial public offering (the "IPO").
About Iambic Therapeutics
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
- Ticker
- IAM
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Listed
- Oct 15, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Iambic Therapeutics IPO price?
$16.00 a share.
When did Iambic Therapeutics go public?
Iambic Therapeutics listed on Nasdaq on Oct 15, 2026 under the ticker IAM.
How much did the Iambic Therapeutics IPO raise?
$150M, before any underwriters' option.
How did Iambic Therapeutics open on its first day?
IAM first traded at $16.15, +0.94% from the IPO price of $16.00.
How did IAM close on its first day?
Its last regular-session trade was $18.91, +18.19% from the IPO price of $16.00.
What was the IAM first-day trading range?
$16.15 to $19.70 in the regular session.
How many IAM shares traded on the first day?
1.93M shares in the regular session.
How many shares did Iambic Therapeutics sell in its IPO?
9.38M shares.
What exchange is IAM listed on?
Iambic Therapeutics lists on Nasdaq under the ticker IAM.
Are the prices on this page real time?
No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.
Build with Massive
Get the IAM data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/IAM/range/5/minute |
| Market cap | /v3/reference/tickers/IAM |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.